Latest

anxiety

·October 21, 2024·3 min read

Why PTSD Develops in Some but Not Others

Fear memories initially form broad associations, but over time, they shift to become episodic memories tied to specific timelines. This process involves the hippocampus early on, with the dorsolateral prefrontal cortex integrating the event sequence later.

This shows a woman relaxing with headphones on.

Featured Neuroscience Pain Psychology

·October 19, 2024·4 min read

Listening to Music After Surgery Lowers Pain and Anxiety

A new study suggests that listening to music after surgery can significantly reduce pain, anxiety, and even heart rate, aiding recovery. An analysis of 35 studies found that patients who listened to music reported lower pain levels and used less morphine on the first day post-surgery compared to those who didn’t.

Featured Genetics Neuroscience Psychology

·October 11, 2024·5 min read

Newly Discovered Protein Complex Shapes Synapses and Mental Health

Researchers have identified a protein complex, TrkC-PTPσ, that plays a key role in the structural organization of synapses in the brain, impacting cognitive behaviors. By studying this complex, scientists uncovered how it regulates synaptic protein phosphorylation, essential for healthy brain function. Disruptions in this protein complex led to anxiety-like behaviors in mice, providing insights into mental health conditions like anxiety and autism.

This shows a child thinking about a traumatic event.

Featured Neuroscience Psychology

·October 11, 2024·6 min read

Child Trauma Recovery Tied to Thoughts, Not Event Severity

A new study reveals that how children mentally process traumatic events is the most significant factor in predicting their mental health outcomes, including PTSD, anxiety, and depression. Cognitive factors—like how children remember the event and view themselves afterward—play a more critical role than the event’s objective severity. Researchers found that children with more negative self-perceptions or distorted memories were at higher risk for long-term psychological impacts.

Featured Genetics Neuroscience Psychology

·October 5, 2024·5 min read

Gene Activity in Depression Linked to Immune System and Inflammation

A new study reveals that inflammation and immune system activation are closely linked to major depressive disorder (MDD), particularly in those resistant to standard antidepressants. Researchers analyzed gene expression in people with depression, finding increased immune-related gene activity, especially in those with higher inflammation.

Featured Neuroscience Psychology

·October 4, 2024·3 min read

Targeting Liver X Receptor Beta for Depression Treatment

A recent review highlights the potential of liver X receptor beta (LXRβ) as a target for treating depression and anxiety. Known for regulating cholesterol, LXRβ is emerging as a key player in mental health, with research showing its role in balancing neurotransmission and enhancing cognitive function.

This shows a woman and psychedelic swirls.

Featured Neuroscience Psychology

·October 3, 2024·4 min read

Psychedelics Reduce Anxiety Without Hallucinations

New research has pinpointed the specific brain region and neuron type responsible for reducing anxiety using the psychedelic drug DOI, without triggering hallucinations. The study revealed that DOI targets serotonin2A receptors on parvalbumin-positive neurons in the ventral hippocampus, decreasing anxiety behaviors in animal models.

Featured Neuroscience Psychology

·September 30, 2024·4 min read

Gender Nonconformity Linked to Increased Mental Health Risks

A recent study found that individuals who display traits or behaviors that differ from traditional gender stereotypes are at a higher risk of mental health issues, including anxiety, depression, and low self-esteem. The research, which analyzed data from up to 142,000 participants, revealed that gender nonconformity is more strongly linked to mental health difficulties in men and adolescents.

Featured Neuroscience Psychology

·September 24, 2024·3 min read

Psychedelic Drug Reduces Anxiety by Targeting Fast-spiking Interneurons

The psychedelic DOI, a compound similar to LSD, reduced anxiety in mice by activating specific brain cells called fast-spiking interneurons. These neurons silence nearby cells in the ventral hippocampus, a region linked to emotion and memory. By uncovering this mechanism, the study opens the door to designing new treatments that target anxiety without triggering hallucinations, a hallmark of many psychedelics.

Featured Genetics Neuroscience Psychology

·September 22, 2024·3 min read

100+ Genes Linked to Anxiety Disorders Identified

A large-scale genetic study involving over 1 million participants has uncovered more than 100 genes associated with anxiety. Researchers found that these genes contribute to the development of anxiety disorders and are also linked to other mental and physical health conditions, such as depression and gastrointestinal disorders.

Featured Genetics Neuroscience

·September 5, 2024·2 min read

RNA Therapy Improves Memory and Reduces Anxiety

An RNA-based therapy, COG-201, can enhance memory and reduce anxiety in animal models by targeting the serotonin 5-HT2A receptor. Scientists found that decreasing this receptor’s expression led to improved cognitive function and reduced anxiety-like behaviors in mice and rats.

Featured Neuroscience Psychology

·August 23, 2024·5 min read

Knowingly Taking Placebos Reduces Stress and Anxiety

Researchers have discovered that nondeceptive placebos—placebos given with the full knowledge that they are placebos—can effectively manage stress, even when administered remotely. In a two-week randomized controlled trial, participants experiencing prolonged stress were divided into two groups: one group received nondeceptive placebos, while the other served as a control.